• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Kimmie Ng, MD, MPH

Publications

  • Jung S, Qian ZR, Yamauchi M, Bertrand KA, Fitzgerald KC, Inamura K, Kim SA, Mima K, Sukawa Y, Zhang X, Wang M, Smith-Warner SA, Wu K, Fuchs CS, Chan AT, Giovannucci EL, Ng K, Cho E, Ogino S, Nishihara R.Predicted 25(OH)D score and colorectal cancer risk according to vitamin D receptor expression.Cancer Epidemiol Biomarkers Prev. 2014 Jun 11.
    24920642
  • Wolpin BM, Rubinson DA, Wang X, Chan JA, Cleary JM, Enzinger PC, Fuchs CS, McCleary NJ, Meyerhardt JA, Ng K, Schrag D, Sikora AL, Spicer BA, Killion L, Mamon H, Kimmelman AC.Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma.Oncologist. 2014 Jun;19(6):637-8.
    24821822
  • Hiraki LT, Joshi AD, Ng K, Fuchs CS, Ma J, Hazra A, Peters U, Karlson EW, Giovannucci E, Kraft P, Chan AT.Joint effects of colorectal cancer susceptibility Loci, circulating 25-hydroxyvitamin d and risk of colorectal cancer.PLoS ONE. 2014;9(3):e92212.
    24670869
  • Chandler PD, Scott JB, Drake BF, Ng K, Forman JP, Chan AT, Bennett GG, Hollis BW, Giovannucci EL, Emmons KM, Fuchs CS.Risk of Hypercalcemia in Blacks Taking Hydrochlorothiazide and Vitamin D.Am J Med. 2014 Mar 20.
    24657333
  • Ng K, Scott JB, Drake BF, Chan AT, Hollis BW, Chandler PD, Bennett GG, Giovannucci EL, Gonzalez-Suarez E, Meyerhardt JA, Emmons KM, Fuchs CS.Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial.Am J Clin Nutr. 2014 Mar;99(3):587-98.
    24368437
  • Chandler PD, Scott JB, Drake BF, Ng K, Manson JE, Rifai N, Chan AT, Bennett GG, Hollis BW, Giovannucci EL, Emmons KM, Fuchs CS.Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial.Cancer Prev Res (Phila Pa). 2014 Feb;7(2):218-25.
    24327720
  • Ogino S, Liao X, Imamura Y, Yamauchi M, McCleary NJ, Ng K, Niedzwiecki D, Saltz LB, Mayer RJ, Whittom R, Hantel A, Benson AB, Mowat RB, Spiegelman D, Goldberg RM, Bertagnolli MM, Meyerhardt JA, Fuchs CS, .Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.Journal of the National Cancer Institute. 2013 Dec 4;105(23):1789-98.
    24231454
  • Yuan C, Bao Y, Wu C, Kraft P, Ogino S, Ng K, Qian ZR, Rubinson DA, Stampfer MJ, Giovannucci EL, Wolpin BM.Prediagnostic body mass index and pancreatic cancer survival.J Clin Oncol. 2013 Nov 20;31(33):4229-34.
    24145341
  • Hiraki LT, Qu C, Hutter CM, Baron J, Berndt SI, Bezieau S, Brenner H, Caan BJ, Casey G, Chang-Claude J, Chanock SJ, Conti DV, Duggan D, Fuchs CS, Gallinger S, Giovannucci EL, Harrison TA, Hayes RB, Hazra A, Henderson B, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Küry S, Le Marchand L, Lemire M, Ma J, Manson JE, Nan H, Newcomb PA, Ng K, Potter JD, Schoen RE, Schumacher F, Seminara D, Slattery ML, Wactawski-Wende J, White E, Wu K, Zanke BW, Kraft P, Peters U, Chan AT.Genetic Predictors of Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer.Cancer Epidemiol Biomarkers Prev. 2013 Aug 27.
    23983240
  • Ng K, Tabernero J, Hwang J, Bajetta E, Sharma S, Del Prete SA, Arrowsmith ER, Ryan DP, Sedova M, Jin J, Malek K, Fuchs CS.Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens.Clin Cancer Res. 2013 Jul 15;19(14):3987-95.
    23743569
  • Wolpin BM, Ng K, Zhu AX, Abrams T, Enzinger PC, McCleary NJ, Schrag D, Kwak EL, Allen JN, Bhargava P, Chan JA, Goessling W, Blaszkowsky LS, Supko JG, Elliot M, Sato K, Regan E, Meyerhardt JA, Fuchs CS.Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer.Oncologist. 2013 Apr 11.
    23580238
  • Rubinson DA, Hochster HS, Ryan DP, Wolpin BM, McCleary NJ, Abrams TA, Chan JA, Iqbal S, Lenz HJ, Lim D, Rose J, Bekaii-Saab T, Chen HX, Fuchs CS, Ng K.Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients.Invest New Drugs. 2013 Apr 9.
    23568716
  • Morikawa T, Kuchiba A, Lochhead P, Nishihara R, Yamauchi M, Imamura Y, Liao X, Qian ZR, Ng K, Chan AT, Meyerhardt JA, Giovannucci E, Fuchs CS, Ogino S.Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.Cancer Res. 2013 Mar 1;73(5):1600-10.
    23442321
  • McCleary NJ, Wigler D, Berry D, Sato K, Abrams T, Chan J, Enzinger P, Ng K, Wolpin B, Schrag D, Fuchs CS, Hurria A, Meyerhardt JA.Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy.Oncologist. 2013;18(1):64-72.
    23287880
  • Ng K, Ogino S, Meyerhardt JA, Chan JA, Chan AT, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Benson AB, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Bertagnolli MM, Venook AP, Fuchs CS.Relationship Between Statin Use and Colon Cancer Recurrence and Survival: Results From CALGB 89803.Journal of the National Cancer Institute. 2011 Oct 19;103(20):1540-51.
    21849660
  • Lee JE, Baba Y, Ng K, Giovannucci E, Fuchs C, Ogino S, Chan AT.Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies.Cancer Prev Res (Phila Pa). 2011 Jun 16.
    21680706
  • Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, Hollis BW, Pollak MN, Fuchs CS.Vitamin D Status in Patients With Stage IV Colorectal Cancer: Findings From Intergroup Trial N9741.J Clin Oncol. 2011 Mar 21.
    21422438
  • Bao Y, Nimptsch K, Meyerhardt J, Chan AT, Ng K, Michaud DS, Brand-Miller JC, Willett WC, Giovannucci E, Fuchs CS.Dietary insulin load, dietary insulin index, and colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3020-6.
    20924099
  • Ng K.Effects of vitamin d in colorectal cancer.Clin Adv Hematol Oncol. 2010 Aug;8(8):533-4.
    20966888
  • Ng K, Meyerhardt JA, Chan JA, Niedzwiecki D, Hollis DR, Saltz LB, Mayer RJ, Benson AB, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Fuchs CS.Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.J Clin Oncol. 2010 Oct 1;28(28):4354-63.
    20805450
  • Ng K, Schrag D.Microsatellite Instability and Adjuvant Fluorouracil Chemotherapy: A Mismatch?.J Clin Oncol. 2010 Jul 10;28(20):3207-10.
    20498398
  • Baba Y, Nosho K, Shima K, Goessling W, Chan AT, Ng K, Chan JA, Giovannucci EL, Fuchs CS, Ogino S.PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):822-31.
    20200425
  • Makhija S, Amler LC, Glenn D, Ueland FR, Gold MA, Dizon DS, Paton V, Lin CY, Januario T, Ng K, Strauss A, Kelsey S, Sliwkowski MX, Matulonis U.Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.J Clin Oncol. 2010 Mar 1;28(7):1215-23.
    19901115
  • Kure S, Nosho K, Baba Y, Irahara N, Shima K, Ng K, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S.Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2765-72.
    19789368
  • Meyerhardt JA, Ogino S, Kirkner GJ, Chan AT, Wolpin B, Ng K, Nosho K, Shima K, Giovannucci EL, Loda M, Fuchs CS.Interaction of molecular markers and physical activity on mortality in patients with colon cancer.Clin Cancer Res. 2009 Sep 15;15(18):5931-6.
    19723652
  • Ng K, Wolpin BM, Meyerhardt JA, Wu K, Chan AT, Hollis B, Giovannucci EL, Stampfer MJ, Willett WC, Fuchs CS.Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.Br J Cancer.;101(6):916-23.
  • Wolpin BM,Meyerhardt JA,Chan AT,Ng K,Chan JA,Wu K,Pollak MN,Giovannucci EL,Fuchs CS.Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.J Clin Oncol. 2009 Jan 10;27(2):176-85.
    19064975
  • Wolpin BM,Wei EK,Ng K,Meyerhardt JA,Chan JA,Selhub J,Giovannucci EL,Fuchs CS.Prediagnostic plasma folate and the risk of death in patients with colorectal cancer.J Clin Oncol. 2008 Jul 1;26(19):3222-8.
    18591557
  • Ng K,Meyerhardt JA,Wu K,Feskanich D,Hollis BW,Giovannucci EL,Fuchs CS.Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.J Clin Oncol. 2008 Jun 20;26(18):2984-91.
    18565885
  • Ng K, Zhu AX.Targeting the epidermal growth factor receptor in metastatic colorectal cancer.Crit Rev Oncol Hematol. 2008 Jan;65(1):8-20. Review.
    18006328
  • Ng K, Meyerhardt JA, Fuchs CS.Adjuvant and neoadjuvant approaches in gastric cancer.Cancer J.;13(3):168-74. Review.
    17620766
  • Agus DB, Sweeney CJ, Morris MJ, Mendelson DS, McNeel DG, Ahmann FR, Wang J, Derynck MK, Ng K, Lyons B, Allison DE, Kattan MW, Scher HI.Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy.J Clin Oncol. 2007 Feb 20;25(6):675-81.
    17308272
  • Gordon MS, Matei D, Aghajanian C, Matulonis UA, Brewer M, Fleming GF, Hainsworth JD, Garcia AA, Pegram MD, Schilder RJ, Cohn DE, Roman L, Derynck MK, Ng K, Lyons B, Allison DE, Eberhard DA, Pham TQ, Dere RC, Karlan BY.Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status.J Clin Oncol. 2006 Sep 10;24(26):4324-32.
    16896006
  • Lewis JD, Ng K, Hung KE, Bilker WB, Berlin JA, Brensinger C, Rustgi AK.Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy.Arch Intern Med. 2003 Feb 24;163(4):413-20.
    12588199